Literature DB >> 11756732

Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.

Martin G Mack1, Jörn O Balzer, Ralf Straub, Katrin Eichler, Thomas J Vogl.   

Abstract

PURPOSE: To compare findings on superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) images of the head and neck with those from resected lymph node specimens and to determine the effect of such imaging on surgical planning in patients with histopathologically proved squamous cell carcinoma of the head and neck.
MATERIALS AND METHODS: Thirty patients underwent MR imaging with nonenhanced and SPIO-enhanced (2.6 mg Fe/kg intravenously) T1-weighted (500/15 [repetition time msec/echo time msec]) and T2-weighted (1,900/80) spin-echo and T2-weighted gradient-echo (GRE) (500/15, 15 degrees flip angle) sequences. Signal intensity decrease was measured, and visual analysis was performed. Surgical plans were modified, if necessary, according to MR findings. Histopathologic and MR findings were compared.
RESULTS: Histopathologic evaluation of 1,029 lymph nodes revealed 69 were metastatic. MR imaging enabled detection of 59 metastases. Regarding lymph node levels, MR diagnosis was correct in 26 of 27 patients who underwent surgery: Only one metastasis was localized in level II with MR imaging, whereas histopathologic evaluation placed it at level III. Extent of surgery was changed in seven patients. SPIO-enhanced T2-weighted GRE was the best sequence for differentiating between benign and malignant lymph nodes.
CONCLUSION: SPIO-enhanced MR imaging has an important effect on planning the extent of surgery. On a patient basis, SPIO-enhanced MR images compared well with resected specimens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756732     DOI: 10.1148/radiol.2221010225

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  37 in total

Review 1.  Assessment of response to therapy using conventional imaging.

Authors:  Sheila C Rankin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-27       Impact factor: 9.236

Review 2.  Imaging of carotid artery disease: from luminology to function?

Authors:  J H Gillard
Journal:  Neuroradiology       Date:  2003-09-04       Impact factor: 2.804

Review 3.  [Post-therapeutic imaging strategies and follow-up in head and neck malignant tumours].

Authors:  R Aschenbach; D Esser
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

4.  Head and neck cancer: how imaging predicts treatment outcome.

Authors:  Robert Hermans
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

Review 5.  [Molecular and parametric imaging with iron oxides].

Authors:  L Matuszewski; B Tombach; W Heindel; C Bremer
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

6.  [Radiological normal anatomy of the larynx and pharynx and imaging techniques].

Authors:  S F Nemec; C R Krestan; I M Noebauer-Huhmann; M Formanek; J Frühwald; P Peloschek; F Kainberger; C Czerny
Journal:  Radiologe       Date:  2009-01       Impact factor: 0.635

7.  Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.

Authors:  Chengli Yang; Antonina Rait; Kathleen F Pirollo; John A Dagata; Natalia Farkas; Esther H Chang
Journal:  Nanomedicine       Date:  2008-07-26       Impact factor: 5.307

8.  Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.

Authors:  R B J de Bondt; M C Hoeberigs; P J Nelemans; W M L L G Deserno; C Peutz-Kootstra; B Kremer; R G H Beets-Tan
Journal:  Neuroradiology       Date:  2009-01-10       Impact factor: 2.804

9.  Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.

Authors:  Takaya Tokuhara; Nobuhiko Tanigawa; Mitsuru Matsuki; Eiji Nomura; Hideaki Mabuchi; Sang-Woong Lee; Yoshiaki Tatsumi; Haruto Nishimura; Ryoji Yoshinaka; Yoshitaka Kurisu; Isamu Narabayashi
Journal:  Gastric Cancer       Date:  2009-01-08       Impact factor: 7.370

10.  Ex-vivo cellular MRI with b-SSFP: quantitative benefits of 3T over 1.5 T.

Authors:  Soha Said Ramadan; Chris Heyn; Lisa T Mackenzie; Ann F Chambers; Brian K Rutt; Paula J Foster
Journal:  MAGMA       Date:  2008-06-25       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.